A Study on Efficacy and Safety of Topiramate in the Treatment of Patients With Obesity
Status:
Completed
Trial end date:
2002-06-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to compare the efficacy and safety of topiramate (96, 192, and
256mg daily) with placebo in long-term treatment of obesity.
Phase:
Phase 3
Details
Lead Sponsor:
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.